The core activity of Kugelmeiers Ltd. is the development and provision of technologies and products for regenerative medicine, particularly for cell therapy and the development of 3D-spheroids for medical applications. The company focuses on creating platforms and products that enable cell therapies to be made safe, efficient and accessible to all.
AI-generated
Offering
Products & services
Industry:Medical Technology Industry
✓ Offered
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
3D cell culture technologies for research, diagnostics and regenerative medicine, for producing standardized cell spheroids and for applications usable in translational contexts.
Sphericalplate 5D®
Patented platform for controlled, scalable spheroid formation with standardized cell cultures, reproducible results and applications in research, diagnostics and therapy.
96-well Strip Format
96-well strip format for flexible experiment planning in 3D cell culture, with data collection from multiple individuals in a small volume.
Plates for 3D cell culture
24-well and 6-well plates for entry and scaling up 3D cell culture with standardized spheroid production.
Applications for diagnostics
3D spheroid models for drug screening, toxicity testing and patient-derived testing approaches for personalized medicine.
Applications for regenerative medicine and cell therapy
3D spheroid approaches for cell therapy, tissue replacement and regenerative medicine, focusing on cell survival, differentiation and integration.
Knowledge
No knowledge articles yet
Once Kugelmeiers AG has claimed this profile, we'll publish editorial articles and case studies here together.